# Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery

> **NCT02080104** · NA · UNKNOWN · sponsor: **Hediye Dagdeviren** · enrollment: 2 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** intarvenous and intramusculer 10 IU oxytocin

## Key facts

- **NCT ID:** NCT02080104
- **Lead sponsor:** Hediye Dagdeviren
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2014-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080104, "Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02080104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*